TG Therapeutics Inc (NASDAQ:TGTX)

14.60
Delayed Data
As of Jun 20
 +0.65 / +4.66%
Today’s Change
7.25
Today|||52-Week Range
17.35
+78.05%
Year-to-Date

Today’s Trading

Previous close13.95
Today’s open14.10
Day’s range13.83 - 14.65
Volume1,657,093
Average volume (3 months)1,163,645
Market cap$1.1B
Data as of 4:00pm ET, 06/20/2018

Growth & Valuation

Earnings growth (last year)-19.37%
Earnings growth (this year)-6.98%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,340.12
Price/Book15.07

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+2.40+7.22%
ADROAduro Biotech Inc-0.20-2.44%
EGRXEagle Pharmaceutical...-0.87-1.16%
ENTAEnanta Pharmaceutica...+1.13+0.99%
Data as of 4:00pm ET, 06/20/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$152.4K
Annual profit (last year)-$118.5M
Net profit margin-77,749.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
Chief Financial Officer, Secretary &
Treasurer
Sean A. Power
Corporate headquarters
New York, New York

Forecasts